- Home
- TNYA vs UCL Comparison
TNYA vs UCL Comparison
Compare TNYA & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- UCL
- Stock Information
- Founded
- TNYA 2016
- UCL 2014
- Country
- TNYA United States
- UCL Hong Kong
- Employees
- TNYA N/A
- UCL N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- UCL Telecommunications Equipment
- Sector
- TNYA Health Care
- UCL Consumer Discretionary
- Exchange
- TNYA Nasdaq
- UCL Nasdaq
- Market Cap
- TNYA 73.8M
- UCL 70.6M
- IPO Year
- TNYA 2021
- UCL 2020
- Fundamental
- Price
- TNYA $0.63
- UCL $1.96
- Analyst Decision
- TNYA Strong Buy
- UCL
- Analyst Count
- TNYA 5
- UCL 0
- Target Price
- TNYA $8.60
- UCL N/A
- AVG Volume (30 Days)
- TNYA 3.0M
- UCL 60.5K
- Earning Date
- TNYA 08-07-2025
- UCL 08-13-2025
- Dividend Yield
- TNYA N/A
- UCL N/A
- EPS Growth
- TNYA N/A
- UCL N/A
- EPS
- TNYA N/A
- UCL 0.09
- Revenue
- TNYA N/A
- UCL $92,256,000.00
- Revenue This Year
- TNYA N/A
- UCL $6.09
- Revenue Next Year
- TNYA N/A
- UCL $7.01
- P/E Ratio
- TNYA N/A
- UCL $19.94
- Revenue Growth
- TNYA N/A
- UCL 7.65
- 52 Week Low
- TNYA $0.36
- UCL $0.80
- 52 Week High
- TNYA $4.06
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- TNYA 53.87
- UCL 60.35
- Support Level
- TNYA $0.54
- UCL $1.79
- Resistance Level
- TNYA $0.70
- UCL $2.17
- Average True Range (ATR)
- TNYA 0.06
- UCL 0.19
- MACD
- TNYA 0.00
- UCL -0.01
- Stochastic Oscillator
- TNYA 34.57
- UCL 41.94
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.